Celera and Abbott Enter Collaboration to Identify Pharmacogenomic Markers.

Extract


Celera and Abbott Enter Collaboration to Identify Pharmacogenomic Markers.

ALAMEDA, Calif. -- Celera Corporation (NASDAQ:CRA) today announced that it has entered into a research collaboration with Abbott to identify genetic markers for one of Abbott's investigational c...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company